If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTUNG.L Regulatory News (TUNG)

  • There is currently no data for TUNG

Directorate Change

14 Feb 2019 07:00

RNS Number : 9497P
Tungsten Corporation PLC
14 February 2019
 

FOR IMMEDIATE RELEASE

14 February 2019

TUNGSTEN CORPORATION PLC

 ("Tungsten" or the "Company")

Resignation of CEO

Tungsten Corporation (AIM: TUNG) announces that Richard Hurwitz, Chief Executive Officer, has informed the Board of his resignation from the Board with immediate effect. He will leave the Company on 15 February 2019.

Tungsten has appointed headhunters to identify a new CEO and expects to make an appointment in March 2019. In the meantime, Tony Bromovsky has moved from Non-Executive to Executive Chairman on an interim basis and David Williams, Chief Financial Officer, will oversee day-to-day operations. As announced on 11 February 2019, Vivienne Maclachlan has also joined the Board as a Non-Executive Director.

Trading for November and December 2018 was in line with expectations and demonstrates the progress being made through the Operating Review. Unaudited revenue for the two months was approximately £6.3 million and EBITDA was positive. Net cash at 31 December 2018 was £1.8 million, growing to £2.5 million at 31 January 2019. The Company is planning to release details of its third quarter trading to 31 January 2019 on 25 February 2019. Tungsten reiterates its full-year FY19 outlook, including revenue expectation of £36 million to £36.5 million, EBITDA profit for the full financial year and sufficient capital to deliver current plans.

As reported in Tungsten's Interim Results on 13 December 2018, the new and refreshed Board, together with senior management, are currently undertaking an operating review addressing all aspects of Tungsten's business (the "Operating Review"). The Operating Review has already substantiated many of Tungsten's strengths. It has also clearly identified a number of growth inhibitors and demonstrated how they can be rapidly and effectively addressed. The review is now focused on the steps required to accelerate near-term revenue and profitability growth. Significant progress has already been made towards this and more is currently being done. The Board of Tungsten expects to complete the Operating Review by April 2019 and thereafter implement the recommended outcomes in close collaboration with the new CEO.

Tony Bromovsky, Chairman, commented:

"The Board wishes to thank Rick for his valuable contribution to the Company since his appointment as CEO in 2015 and we wish him well in his future endeavours."

This announcement contains inside information for the purposes of the Market Abuse Regulation No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

For further information please contact:

Tungsten Corporation plc

Tony Bromovsky, Chairman

David Williams, Chief Financial Officer

 

 

 

+44 20 7280 7713

 

Panmure Gordon (Nominated Adviser)

Dominic Morley

 

+44 20 7886 2500

 

 

Canaccord Genuity Limited (Financial Adviser and Broker)

Simon Bridges/Miles Cox/Emma Gabriel

 

+44 20 7523 8000

 

 

 

About Tungsten Corporation plc

Tungsten Corporation (LSE: TUNG) aims to be the world's most trusted business transaction network by using data intelligently to strengthen the global supply chain.

 

Tungsten Network is a secure business transaction network that brings businesses and their suppliers closer together with unique technology that revolutionises invoice processing, maximises efficiency and improves cash flow. Delivering trusted connections and streamlined transactions, the network also provides users with real-time spend analysis and offers access to trade finance through Tungsten Network Finance.

 

Tungsten Network processes invoices for 74 percent of the FTSE 100 and 71 percent of the Fortune 500. It enables suppliers to submit tax compliant e-invoices in 48 countries, and last year processed transactions worth over £164bn for organisations such as Alliance Data, Cargill, Deutsche Lufthansa, General Motors, GlaxoSmithKline, Mondelēz International, Henkel, IBM, Kellogg's and the US Federal Government.

 

Forward looking statements

 

This document contains forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. Any forward-looking statement is based on information available to Tungsten as of the date of this statement. All written or oral forward-looking statements attributable to Tungsten are qualified by this caution. Tungsten does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Tungsten's expectations.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAVXLFFKLFLBBL
Date   Source Headline
23rd Mar 20212:15 pmRNSCustomer Loss
17th Mar 20214:35 pmRNSPrice Monitoring Extension
16th Mar 20214:40 pmRNSSecond Price Monitoring Extn
16th Mar 20214:36 pmRNSPrice Monitoring Extension
12th Feb 20217:00 amEQSTungsten (TUNG): Foundations for growth in place
19th Jan 20214:15 pmRNSHolding(s) in Company
19th Jan 20214:10 pmRNSHolding(s) in Company
15th Jan 20214:36 pmRNSPrice Monitoring Extension
6th Jan 202111:00 amRNSHolding(s) in Company
4th Jan 20217:00 amRNSHolding(s) in Company
18th Dec 20204:30 pmRNSHolding(s) in Company
14th Dec 20207:00 amRNSInterim Results
11th Dec 20207:00 amRNSNew Customer Win
10th Dec 20201:05 pmRNSHolding(s) in Company
1st Dec 20204:40 pmRNSSecond Price Monitoring Extn
1st Dec 20204:35 pmRNSPrice Monitoring Extension
27th Nov 20207:00 amRNSTrading Update
2nd Nov 20204:31 pmRNSAdditional Listing and Total Voting Rights
2nd Nov 20204:30 pmRNSDirector/PDMR Shareholding
23rd Oct 20201:05 pmRNSHolding(s) in Company
20th Oct 20207:00 amRNSAppointment of Non-Executive Director
16th Oct 20203:50 pmRNSResult of AGM
15th Oct 20205:49 pmRNSAdditional Listing and TVR
2nd Oct 20207:00 amRNSAdditional Listing and Total Voting Rights
23rd Sep 20207:00 amRNSBlock Listing Application
15th Sep 202012:30 pmRNSHolding(s) in Company
11th Sep 20207:00 amRNSDirectorate Change
9th Sep 20207:00 amRNSHolding(s) in Company
7th Sep 20207:00 amRNSFinal Results
20th Jul 20207:00 amRNSTrading Update
2nd Jul 20201:00 pmRNSHolding(s) in Company
22nd Jun 20207:00 amRNSReporting Timetable
17th Apr 20207:00 amRNSAppointment of Chief Financial Officer
3rd Apr 202012:05 pmRNSDirector/PDMR Share Dealing
2nd Apr 20202:15 pmRNSDirector/PDMR Share Dealing
31st Mar 20201:40 pmRNSAppointment of Non Executive Director
31st Mar 202012:07 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
31st Mar 202011:16 amRNSChange of Nominated Adviser
23rd Mar 20207:00 amRNSCOVID-19 Update
19th Mar 202011:45 amRNSDirector/PDMR Share Dealing
16th Mar 20201:15 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSTrading Update for the Nine Months to 31 Jan 2020
6th Mar 202012:07 pmRNSSecond Price Monitoring Extn
6th Mar 202012:02 pmRNSPrice Monitoring Extension
5th Feb 20202:46 pmRNSDIRECTORATE CHANGE UPDATE
4th Feb 20204:40 pmRNSSecond Price Monitoring Extn
4th Feb 20204:35 pmRNSPrice Monitoring Extension
22nd Jan 20207:00 amRNSDIRECTORATE CHANGE
10th Jan 20204:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.